IBD Treatment Market - Top Companies and Manufacturers

Companies Dominating the Inflammatory Bowel Disease Treatment Landscape

The Bristol-Myers Squibb Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Bausch Health Companies Inc.
AbbVie Inc.
Novartis AG
UCB Biopharma SRL
Biogen Inc.
Pfizer, Inc.
Janssen Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Celltrion Healthcare Co., Ltd.

Browse Key Market Insights with Data Illustration:

Inflammatory Bowel Disease Treatment Market Size Forecasts 2037

In the News

The Bristol-Myers Squibb Company to announce that Zeposia (ozanimod) has been given marketing authorization by the European Commission for the treatment of individuals with moderately to highly active ulcerative colitis. Zeposia is orally administered and recommended to be taken once a day. It is the only oral S1P receptor modulator and first innovative method to cure this chronic immune-mediated disease with high efficiency.
Bausch Health Companies Inc.- Salix (a subsidiary of Bausch Health Companies Inc.) and Mitsubishi Tanabe Pharma have an exclusive license agreement for the development and marketing of a late-stage investigational S1P modulator for the treatment of inflammatory bowel disease.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of inflammatory bowel disease treatment is evaluated at USD 24.69 billion.

The inflammatory bowel disease treatment market size was valued at USD 23.26 billion in 2024 and is likely to exceed USD 60.79 billion by the end of 2037, registering over 7.6% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of Crohn's disease and growing spending on rare disease will boost the market growth.

North America industry is projected to account for largest revenue share by 2037, impelled by high prevalence and rising incidence of ulcerative colitis and Crohn's disease in the region.

The major players in the market include Bausch Health Companies Inc., AbbVie Inc., Novartis AG, UCB Biopharma SRL, Biogen Inc., Pfizer, Inc., Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

IBD Treatment Market - Top Companies and Manufacturers

Companies Dominating the Inflammatory Bowel Disease Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the inflammatory bowel disease treatment market?

What are the factors driving the inflammatory bowel disease treatment landscape?

Which region held the largest inflammatory bowel disease treatment industry share?

Who are the key players in the inflammatory bowel disease treatment sector?